3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
19
Paclitaxel
10
Carboplatin
10
Magnetic Resonance Spectroscopy
9
Docetaxel
9
Cyclophosphamide
9
Specimen Handling
8
Cisplatin
8
Gemcitabine
7
Drug Therapy
7
sargramostim
6
Pemetrexed
6
Nivolumab
6
fludarabine
5
aldesleukin
5
Trastuzumab
5
Bevacizumab
5
Taxes
4
Fluorouracil
4
Blood Specimen Collection
4
Amifostine
4
veliparib
3
pegfilgrastim
3
Topotecan
3
Irinotecan
3
IFL protocol
3
Fluorodeoxyglucose F18
3
Etoposide
3
Early Intervention, Educational
3
tariquidar
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Patient-Specific Modeling
×
Gynecologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn